Literature DB >> 33568044

Elevated MST1 leads to apoptosis via depletion of YAP1 in cardiomyocytes exposed to high glucose.

Dongmei Su1,2, Yanhua Li3,4, Lina Guan1, Qian Li1, Cuige Shi1, Xu Ma5,6, Yonghui Song4.   

Abstract

BACKGROUND: Gestational diabetes mellitus is a risk factor for congenital heart defects. The article aimed to investigate the expression and roles of MST1, YAP1, Last1/2 and Survivin in modulating HG-induced cardiomyocyte apoptosis and maternal diabetes-induced heart abnormality.
METHODS: Diabetes mellitus was induced in rats using streptozotocin. The protein expression and phosphorylation analysis in fetal heart tissue was assessed by western blot and immunohistochemical staining. Hoechst 33342 staining assay was performed to explore H9C2 apoptosis. The gene and protein expression in H9C2 cells was assessed by quantitative PCR and western blot. Knockdown of gene expression was assessed by RNA interference.
RESULTS: Our results revealed that increased MST1 protein levels in the heart tissues of the offspring of diabetic rats in vivo and in H9C2 cardiomyocytes under HG treatment in vitro, respectively. Knockdown and overexpression experiments showed that MST1 played a key role in mediating HG-induced apoptosis in cardiomyocytes. Downregulation of YAP1 was associated with HG-induced, MST1-mediated cardiomyocyte apoptosis. Further study showed that MST1 downregulated the protein level of YAP1 through mediation of YAP1 phosphorylation on Ser127 and Ser397; this process also required LATS1/2 participation. MST1 overexpression increased the phosphorylation levels of LATS1/2, which were also shown to be increased in the heart tissues of diabetic offspring. We also found that YAP1 mediated the expression of Survivin during HG-induced apoptosis, and the Survivin-inhibitor YM155 partially inhibited the role of YAP1 in suppressing apoptosis induced by HG in cardiomyocytes.
CONCLUSION: These findings reveal a regulatory mechanism of MST1/YAP1/Survivin signaling in modulating cardiomyocyte apoptosis in vitro and maternal diabetes-induced congenital heart defects in vivo.

Entities:  

Keywords:  Cardiomyocyte apoptosis; High glucose; MST1; Survivin; YAP1

Mesh:

Substances:

Year:  2021        PMID: 33568044      PMCID: PMC7874454          DOI: 10.1186/s10020-021-00267-6

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.376


  34 in total

1.  The Legionella Effector Kinase LegK7 Hijacks the Host Hippo Pathway to Promote Infection.

Authors:  Pei-Chung Lee; Matthias P Machner
Journal:  Cell Host Microbe       Date:  2018-09-12       Impact factor: 21.023

2.  Mammalian STE20-Like Kinase 1 Deletion Alleviates Renal Ischaemia-Reperfusion Injury via Modulating Mitophagy and the AMPK-YAP Signalling Pathway.

Authors:  Junxia Feng; Hongyan Li; Yunfang Zhang; Qi Wang; Shili Zhao; Ping Meng; Jingchun Li
Journal:  Cell Physiol Biochem       Date:  2018-12-07

3.  Increased susceptibility of HIF-1α heterozygous-null mice to cardiovascular malformations associated with maternal diabetes.

Authors:  Romana Bohuslavova; Lada Skvorova; David Sedmera; Gregg L Semenza; Gabriela Pavlinkova
Journal:  J Mol Cell Cardiol       Date:  2013-04-22       Impact factor: 5.000

4.  Hyperglycemia and adverse pregnancy outcomes.

Authors:  Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

5.  Maternal Midpregnancy Glucose Levels and Risk of Congenital Heart Disease in Offspring.

Authors:  James R Priest; Wei Yang; Gerald Reaven; Joshua W Knowles; Gary M Shaw
Journal:  JAMA Pediatr       Date:  2015-12       Impact factor: 16.193

6.  The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα.

Authors:  Adrian Britschgi; Stephan Duss; Sungeun Kim; Joana Pinto Couto; Heike Brinkhaus; Shany Koren; Duvini De Silva; Kirsten D Mertz; Daniela Kaup; Zsuzsanna Varga; Hans Voshol; Alexandra Vissieres; Cedric Leroy; Tim Roloff; Michael B Stadler; Christina H Scheel; Loren J Miraglia; Anthony P Orth; Ghislain M C Bonamy; Venkateshwar A Reddy; Mohamed Bentires-Alj
Journal:  Nature       Date:  2017-01-09       Impact factor: 49.962

7.  MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.

Authors:  Zhipeng Meng; Toshiro Moroishi; Violaine Mottier-Pavie; Steven W Plouffe; Carsten G Hansen; Audrey W Hong; Hyun Woo Park; Jung-Soon Mo; Wenqi Lu; Shicong Lu; Fabian Flores; Fa-Xing Yu; Georg Halder; Kun-Liang Guan
Journal:  Nat Commun       Date:  2015-10-05       Impact factor: 14.919

8.  Pulse oximetry screening for critical congenital heart disease in planned out of hospital births and the incidence of critical congenital heart disease in the Plain community.

Authors:  K K Miller; K S Vig; E M Goetz; G Spicer; A J Yang; J S Hokanson
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

9.  Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.

Authors:  Kwong-Fai Wong; Angela M Liu; Wanjin Hong; Zhi Xu; John M Luk
Journal:  Oncotarget       Date:  2016-11-22

10.  N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes.

Authors:  Hoda Moazzen; Xiangru Lu; Noelle L Ma; Thomas J Velenosi; Brad L Urquhart; Lambertus J Wisse; Adriana C Gittenberger-de Groot; Qingping Feng
Journal:  Cardiovasc Diabetol       Date:  2014-02-18       Impact factor: 9.951

View more
  3 in total

1.  Role of MiR-27a-3p in Intervertebral Disc Degeneration through Targeting RASSF5 via MST1/LATS1 and RAS/RAC1 Signaling Pathway.

Authors:  Chao Yuan; Jing Zhou; Lei Zhou; Liran Wang; Yong Pan
Journal:  J Healthc Eng       Date:  2022-03-07       Impact factor: 2.682

Review 2.  Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease.

Authors:  Stephanie M Kereliuk; Vernon W Dolinsky
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

Review 3.  The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response.

Authors:  Ancheng Zheng; Qishan Chen; Li Zhang
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.